SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-23
👔
Adicet Bio, Inc.
@ACET_InsiderForm 4 Filing: Schor Chen Acquires (Grant) shares of $ACET
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Adicet Bio, Inc.
Ticker: $ACET
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-19
Shares: 55,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Schor Chen, holds the title of President & CEO at Adicet Bio, Inc..
On 2026-06-19, the insider transacted 55,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Schor Chen (President & CEO) was granted $0 of $ACET
Post-Transaction Position: 55,000 shares
SEC Accession No: 0001340875-26-000007 (CIK: 1340875)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.